10-Q quarterly report · filed Nov 2, 2026

Clorox (CLX) Q3 2026 10-Q Quarterly Report

Short answer

Clorox (CLX) filed its Q3 2026 10-Q quarterly report on Nov 2, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $1.9B (up 33.3% year over year) with net income of $170M.

Q3 2026 key financials · XBRL

Revenue
$1.9B
+33.3% YoY
Net income
$170M
+112.5% YoY
Gross margin
40.4%
EPS (diluted)
$1.39
+113.8% YoY

Source: XBRL data from the Clorox (CLX) Q3 2026 10-Q on SEC EDGAR. USD.

Clorox Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $1,905M, up 33% YoY from $1,429M, driven by GOJO acquisition and lapping ERP-related shipment impacts
  • Gross margin 40.4% vs 41.7% YoY, down 130 basis points from higher commodity, manufacturing and logistics costs
  • Best segment: Health and Wellness sales up 55%, adjusted EBIT up 69%; worst: International sales up 11%, adjusted EBIT up 63%
  • Operating cash flow $143M vs $93M YoY; financing outflows $68M, with $1,175M debt primarily funding GOJO acquisition
  • Outlook: volatile, challenging environment; tariff, consumer spending, commodity and geopolitical headwinds, with continued brand investment and GOJO integration Candida

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Clorox quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.